Exploring the molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43 using molecular dynamics simulation and free energy calculation.

Journal of Computational Chemistry
Han SunWenqing Zheng

Abstract

Transactivation response element RNA/DNA-binding protein 43 (TDP-43) is involved in the regulation of alternative splicing of human neurodegenerative disease-related genes through binding to long UG-rich RNA sequences. Mutations in TDP-43, most in the homeodomain, cause neurological disorders such as amyotrophic lateral sclerosis and fronto temporal lobar degeneration. Several mutants destabilize the structure and disrupt RNA-binding activity. The biological functions of these mutants have been characterized, but the structural basis behind the loss of RNA-binding activity is unclear. Focused on the specific TDP-43-ssRNA complex (PDB code 4BS2), we applied molecular dynamics simulations and the molecular mechanics Poisson-Boltzmann surface area free energy calculation to characterize and explore the structural and dynamic effects between ssRNA and TDP-43. The energetic analysis indicated that the intermolecular van der Waals interaction and nonpolar solvation energy play an important role in the binding process of TDP-43 and ssRNA. Compared with the wild-type TDP-43, the reduction of the polar or non-polar interaction between all the mutants F149A, D105A/S254A, R171A/D174A, F147L/F149L/F229L/F231L and ssRNA is the main reason f...Continue Reading

References

Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
May 15, 1998·Trends in Biochemical Sciences·G D Stormo, D S Fields
Dec 2, 1998·Journal of Biomolecular Structure & Dynamics·T E CheathamP A Kollman
Oct 14, 2000·Annual Review of Physical Chemistry·D Bashford, D A Case
Sep 5, 2002·Journal of Computational Chemistry·Ray LuoMichael K Gilson
Nov 28, 2002·Nature Genetics·Gavin MacBeath
Jul 17, 2004·Science·Charalampos G KalodimosRobert Kaptein
Oct 8, 2004·Journal of the American Chemical Society·Junji IwaharaG Marius Clore
Aug 27, 2010·Clinical Pharmacology and Therapeutics·K A Josephs
Jun 18, 2011·Journal of Molecular Neuroscience : MN·Mauricio Budini, Emanuele Buratti
Nov 22, 2011·Journal of Molecular Biology·Monica PassoniEmanuele Buratti
Mar 19, 2013·Molecular and Cellular Neurosciences·Emanuele BurattiFrancisco E Baralle
Mar 22, 2013·Biotechnology for Biofuels·Ning SunBradley M Holmes
Jun 6, 2013·PloS One·Yi-Chen HuangJoseph Jen-Tse Huang
Sep 11, 2013·The Journal of Organic Chemistry·Kiran R GoreP I Pradeepkumar
Nov 19, 2013·Nature Structural & Molecular Biology·Peter J LukavskyFrédéric H-T Allain
Jan 2, 2014·Human Molecular Genetics·Sen YanXiao-Jiang Li
Nov 10, 2015·Journal of Molecular Graphics & Modelling·Salla I VirtanenOlli T Pentikäinen
Jun 11, 2013·Journal of Chemical Theory and Computation·Irene Maffucci, Alessandro Contini
Jul 25, 2017·Scientific Reports·Lei-Lei JiangHong-Yu Hu
Jun 23, 2020·Journal of Biomolecular Structure & Dynamics·Palanisamy PrakashRengarajan Manivasagaperumal

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Tetsuaki Arai
BioRxiv : the Preprint Server for Biology
Shawn Michael Ferguson, A. Roczniak-Ferguson
© 2021 Meta ULC. All rights reserved